Ascites Market by Human Pathology Types, Detail Analysis and Forecasts To 2023

Market Scenario:    
Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in the pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For a smaller amount of fluid, ultrasound and CT scan are preferred.
According to a study published in the Canadian Journal of Gastroenterology and Hepatology in 2016, serial large volume paracentesis (LVP) is considered as the first-line treatment for refractory ascites, and is also performed in an outpatient every 2 weeks. But there are certain complications associated with LVP such as bleeding, catheter fragmentation into the abdominal wall, and small bowel perforation.
The global ascites market is expected to grow at a CAGR of 4.0% during the forecast period 2017-2023. 

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/1909
Segmentation:    
The global ascites market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of the treatment, the market is segmented into surgeries and others. The surgeries segment is further sub-segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), and other surgeries.
On the basis of the end -users, the market is segmented into hospital, and clinics, ambulatory surgical centers, diagnostic centers, and others.
Intended Audience:    
•    Medical Devices Companies
•    Hospitals & Clinics
•    Diagnostic Centers
•    Research and Development (R&D) Companies
•    Government Research Institute
•    Academic Institutes and Universities 

Regional Analysis:
The Americas dominate the ascites market owing to the well-developed technology, high healthcare expenditure, rising prevalence of cirrhosis, and the presence of the leading players in the region. According to the data suggested by the Centers for Disease Control and Prevention in 2015, around 1.6 % adults have been diagnosed with the chronic liver disease in the United States i.e. 3.9 million. It is also stated that from 2000 to 2015 death rates due to the chronic liver disease and cirrhosis was increased by 31% in the United States among individuals aged 45–64 years.
Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.
The Middle East and Africa hold the least share of the ascites market owing to the presence of poor and slow developing countries, especially, in African region.

Key Players                                                                                                         
Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.
Get Your Customized Report @ https://www.marketresearchfuture.com/reports/ascites-market-1909
Table of Content:
1    REPORT PROLOGUE
2    2  MARKET INTRODUCTIO
3    2.1 Research Objective 15 
2.2 Assumptions & Limitations 15 
2.2.1 Assumptions 15 
2.2.2 Limitations 15 
2.3 Market Structure 16
3  RESEARCH METHODOLOG
3.1 Introduction 17 
3.1.1 Primary Research Methodology 18 
3.1.2 Secondary Research Methodology 19 
3.1.3 Market Share Analysis 20 
3.1.4 Trade Analysis 20 
3.1.5 Market Pricing Approach 21
4  MARKET DYNAMICS
4.1 Introduction 22 
4.2 Drivers 23 
4.2.1 Rising Prevalence Of Cirrhosis (Impact Weightage: 35%) 23 
4.2.2 Improvement In Reimbursement Policies (Impact Weightage: 30%) 24 
4.2.3 Increasing Occurrence Of Cancer (Impact Weightage: 35%) 25 
TOC Continued…!
Get Discount @https://www.marketresearchfuture.com/check-discount/1909 

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.